摘要
目的:探讨采用不同手术方式治疗胃癌对患者术后血清血管内皮生长因子(VEGF)和基质金属蛋白酶-3(MMP-3)水平的影响及意义。方法:运用ELISA法检测18例健康者、31例腹腔镜胃癌根治术者及17例开腹手术者治疗前后血清VEGF和MMP-3的含量。结果:腔镜组与开腹组术前VEGF和MMP-3含量无明显差异(P>0.05),均明显高于健康者(P<0.05)。在术后1周腔镜组VEGF、MMP-3含量下降,低于开腹组,但仍高于健康者(P<0.05)。术后1月腔镜租和开腹组VEGF、MMP-3含量下降,低于术前,但仍高于健康者,腹腔镜组VEGF含量明显低于开腹组(P<0.05)。术后半年两组VEGF、MMP-3含量对比无明显差异,MMP-3降至健康者水平(P>0.05)。但VEGF含量仍高于健康者(P<0.05)。结论:腹腔镜胃癌根治术对患者机体功能影响小,VEGF、MMP-3不会过度表达,不增加肿瘤转移几率,安全可行。
Objective:To study the influence and significance of different operative approaches between pre-and post-treatment on the serum VEGF and MMP-3 of patients with gastric cancer.Methods:To detect the content of serum VEGF,MMP-3 with ELISA method in 18 cases of healthy subjects,and that of the pre-and post-treatment in 31 patients underwent laparoscopic radical gastrectomy and 17 patients underwent open surgery treatment.Results:There was no significant difference(P > 0.05) between the pre-treatment contents of serum VEGF and MMP-3 of patients underwent laparoscopic radical gastrectomy or open surgery treatment,but they were both apparently higher than that of the healthy subjects (P < 0.05).A week after operation,contents of serum VEGF,MMP-3 of patients underwent laparoscopic radical gastrectomy fell and lower than those of the patients underwent open surgery treatment,but still higher than those of the healthy subjects(P < 0.05).A month after operation,contents of serum VEGF and MMP-3 of two groups patients fell lower than that of pre-treatment but still higher than that of healthy subjects.Laparoscopic group VEGF were significantly lower than the open surgery group (P < 0.05).Half a year after operation,the contents of serum MMP-3 of the two groups fell lower than those of healthy subjects (P < 0.05),but the contents of serum VEGF of the two groups still higher than that of healthy subjects(P < 0.05).Conclusion:Laparoscopic radical gastrectomy has a small influence on the body function of patients.It neither causes the overexpression of serum VEGF and MMP-3,nor increases the chances of tumor metastasis,it is safe and accessible.
出处
《现代肿瘤医学》
CAS
2013年第9期2032-2034,共3页
Journal of Modern Oncology